BD has collaborated with Alverix for the development of the digital reader for its BD Veritor System, which employs Alverix’s proprietary optoelectronic and signal detection technologies.

The BD Veritor System provides very good positive and negative percent agreement when measured against polymerase chain reaction (PCR) results.

Alverix CEO Ric Tarbox said following the receipt of 510(k) clearance and CLIA waiver in the US, this is another important achievement for the BD Veritor System.